Press release
Restless Legs Syndrome Therapeutics - Key Players Analysis | Hisamitsu Pharmaceutical Co., Inc., Merz Pharma, AXIM Biotechnologies, Alexza Pharmaceuticals
Download report sample at: https://www.psmarketresearch.com/market-analysis/restless-legs-syndrome-therapeutics/report-sample
*Insights on Pipeline Segments
Around 62% of the pipeline drug candidates are being developed as small molecule for the treatment of RLS. Hisamitsu Pharmaceutical Co., Inc. is in a process to conduct Phase III clinical trial on its developmental drug for the treatment of RLS. In September 2017, AXIM Biotechnologies Inc. announced that it was conducting Phase I and a proof of concept clinical trial (Phase II) of MedChew RL for treatment of RLS in Israel.
*Positive Clinical Trial Results Spur the Growth of RLS Therapeutics Pipeline
The drugs candidates that are being developed by the different pharmaceutical companies have demonstrated positive clinical trial results which in-turn increase their further development. For instance, In April 2017, Merz Pharma GmbH & Co KgaA announced that incobotulinumtoxin demonstrated significant improvement of RLS score in the treatment of subjects with restless leg syndrome.
Browse report at: https://www.psmarketresearch.com/market-analysis/restless-legs-syndrome-therapeutics
*Rise in Patent Approvals for RLS Therapeutics Expected to Provide Collaborative Opportunities to the Pharmaceutical Companies
It has been observed that most of the drug candidates have received or have filed for patent covering a novel mechanism for the treatment of RLS. In April 2017, Omeros Corporation announced that it owned two issued patents and one pending patent application in the U.S., and 21 issued patents and 12 pending patent applications in foreign markets directed to its discoveries linking PDE7 Program - OMS527 to movement disorders. Patent approval help in increasing opportunities for invention improvement and uniqueness.
Pre-Purchase Inquiry at: https://www.psmarketresearch.com/send-enquiry?enquiry-url=restless-legs-syndrome-therapeutics
Some of the key players developing drugs for the treatment of restless leg syndrome include Hisamitsu Pharmaceutical Co., Inc., Merz Pharma GmbH & Co KgaA, AXIM Biotechnologies Inc., and Alexza Pharmaceuticals Inc.
About P&S Intelligence
P&S Intelligence is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.
Contact:
P&S Intelligence
Toll-free: +1-888-778-7886 (USA/Canada)
International: +1-347-960-6455
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Restless Legs Syndrome Therapeutics - Key Players Analysis | Hisamitsu Pharmaceutical Co., Inc., Merz Pharma, AXIM Biotechnologies, Alexza Pharmaceuticals here
News-ID: 1571339 • Views: …
More Releases from P&S Intelligence
U.S. ESG Investments Market Set to Skyrocket: $16 Trillion by 2032
According to the latest market research study published by P&S Intelligence, the U.S. Environmental, Social, and Governance (ESG) investments market is experiencing a significant surge, with projections indicating an increase from $6.5 trillion in 2024 to an estimated $16.0 trillion by 2032. This represents a robust compound annual growth rate (CAGR) of 12.1% over the forecast period.
According to a comprehensive analysis by P&S Intelligence, the market's expansion is driven…
Facility Management in the U.K. Booms with 14.1% CAGR as Demand Soars Across Sec …
According to the latest market research study published by P&S Intelligence, the U.K. facility management market is poised for significant growth, with projected revenues reaching USD 2,743.3 million in 2024 and expected to soar to USD 6,038.4 million by 2030, reflecting a robust CAGR of 14.1% during the forecast period.
This expansion is fueled by a surge in demand across both public and private sectors. According to the RICS U.K.…
Point-of-Sale Software Market in the U.S. Set to Grow by 9.7% CAGR, Boosted by O …
According to the latest market research study published by P&S Intelligence, the U.S. point-of-sale (POS) software market, valued at USD 4.7 billion in 2024, is poised for significant growth over the coming years, with projections estimating it will reach USD 9.8 billion by 2032, expanding at a compound annual growth rate (CAGR) of 9.7%. This growth is attributed to rapid technological advancements, a surge in mobile and cloud-based POS systems,…
Competitive Landscape of the Industrial Starches Market: Key Players, Trends, an …
According to the latest market research study published by P&S Intelligence, the global industrial starches market is poised for significant growth, with a projected increase from USD 110.3 billion in 2024 to USD 169.9 billion by 2030, at a robust compound annual growth rate (CAGR) of 7.5%. Industrial starches play a crucial role in diverse sectors, including food, pharmaceuticals, and paper, driven by their unique properties such as stabilizing, thickening,…
More Releases for RLS
Restless Legs Syndrome (RLS) Epidemiology Market Emerging Trends and Growth Pros …
Introduction
Restless Legs Syndrome (RLS), also known as Willis-Ekbom Disease, is a neurological condition characterized by an uncontrollable urge to move the legs, often accompanied by uncomfortable sensations. It impacts sleep quality, productivity, and overall well-being. Although underdiagnosed historically, rising awareness and improved clinical recognition are fueling demand for effective therapies and accurate epidemiological tracking.
According to Exactitude Consultancy, the global restless legs syndrome epidemiology market was valued at USD 470 million…
New Magnetic Encoder Chip Market Size, Share and Forecast By Key Players-iC-Haus …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global New Magnetic Encoder Chip market is anticipated to grow at a compound annual growth rate (CAGR) of 16.13% between 2024 and 2031. The market is expected to grow to USD 5.68 Billion by 2024. The valuation is expected to reach USD 16.18 Billion by 2031.
The market for new magnetic encoder chips is expanding rapidly because more and more businesses are realizing…
Rotary Limit Switches (RLS) Market Size 2024 to 2031.
Market Overview and Report Coverage
Rotary Limit Switches (RLS) are devices used to control the motion of industrial machinery by limiting its travel. They are essential components in various industries such as manufacturing, automotive, and aerospace to ensure the safe and efficient operation of equipment.
The future outlook of the Rotary Limit Switches (RLS) Market looks promising, with a projected growth at a CAGR of 3.40% during the forecasted period.…
Motor Encoder Market to Eyewitness Stunning Growth by 2028 Covid-19 Analysis | B …
Analysis of the market growth is shown with great accuracy in this Motor Encoder market analysis report. This includes a detailed market summary like snapshots that provide in-depth information of different segmentations. It shows the promising opportunities that are present in the market and move on towards that direction eventually. Market report is a broad framework of the overall market scenario that shows the path to the business entrepreneurs whether…
Rotary Limit Switches (RLS) Market 2021 Through SWOT Analysis with Leading Playe …
“Global Rotary Limit Switches (RLS) Market comes with discretional overview of industry trends, business growth, future advancement, technological study, and analysis forecast to 2027.”
The Rotary Limit Switches (RLS) market is expected to reach USD 219.0 million by 2027 from USD 159.8 million in 2018, at a CAGR of 6.5%.
MarketInsightsReports published a new research publication on “Rotary Limit Switches (RLS)” Market Report, to 2027 and enriched with self-explained data in presentable format. In…
Global Rotary Limit Switches (RLS) Market Expected to Witness a Sustainable Grow …
LP INFORMATION recently released a research report on the Rotary Limit Switches (RLS) market analysis, which studies the Rotary Limit Switches (RLS)'s industry coverage, current market competitive status, and market outlook and forecast by 2025.
Global “Rotary Limit Switches (RLS) Market 2020-2025” Research Report categorizes the global Rotary Limit Switches (RLS) market by key players, product type, applications and regions,etc. The report also covers the latest…
